View Future GrowthBrederode 過去の業績過去 基準チェック /26Brederodeの収益は年間平均-33%の割合で減少していますが、 Capital Markets業界の収益は年間 増加しています。収益は年間1% 36.3%割合で 減少しています。 Brederodeの自己資本利益率は2.9%であり、純利益率は140.1%です。主要情報-32.96%収益成長率-32.96%EPS成長率Capital Markets 業界の成長14.66%収益成長率-36.33%株主資本利益率2.94%ネット・マージン140.12%次回の業績アップデート11 Jun 2026最近の業績更新お知らせ • Jan 09+ 3 more updatesBrederode SA to Report First Half, 2026 Results on Sep 10, 2026Brederode SA announced that they will report first half, 2026 results on Sep 10, 2026お知らせ • Dec 06+ 3 more updatesBrederode SA to Report Nine Months, 2025 Results on Dec 11, 2025Brederode SA announced that they will report nine months, 2025 results on Dec 11, 2025お知らせ • Dec 13+ 4 more updatesBrederode SA to Report Q3, 2024 Results on Dec 05, 2024Brederode SA announced that they will report Q3, 2024 results on Dec 05, 2024お知らせ • Dec 21+ 3 more updatesBrederode SA to Report First Half, 2023 Results on Sep 14, 2023Brederode SA announced that they will report first half, 2023 results on Sep 14, 2023すべての更新を表示Recent updatesBuy Or Sell Opportunity • Feb 25Now 21% overvaluedOver the last 90 days, the stock has fallen 1.5% to €105. The fair value is estimated to be €87.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 16%.お知らせ • Jan 09+ 3 more updatesBrederode SA to Report First Half, 2026 Results on Sep 10, 2026Brederode SA announced that they will report first half, 2026 results on Sep 10, 2026お知らせ • Dec 06+ 3 more updatesBrederode SA to Report Nine Months, 2025 Results on Dec 11, 2025Brederode SA announced that they will report nine months, 2025 results on Dec 11, 2025Buy Or Sell Opportunity • Dec 05Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.5% to €104. The fair value is estimated to be €130, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.Buy Or Sell Opportunity • Nov 12Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at €105. The fair value is estimated to be €132, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.Buy Or Sell Opportunity • Oct 23Now 20% undervaluedOver the last 90 days, the stock has risen 1.8% to €110. The fair value is estimated to be €139, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.Buy Or Sell Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.6% to €112. The fair value is estimated to be €140, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.お知らせ • Dec 13+ 4 more updatesBrederode SA to Report Q3, 2024 Results on Dec 05, 2024Brederode SA announced that they will report Q3, 2024 results on Dec 05, 2024Buying Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.9%. The fair value is estimated to be €118, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Earnings per share has declined by 24%.New Risk • Aug 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risk Shareholders have been diluted in the past year (4.3% increase in shares outstanding).お知らせ • Dec 21+ 3 more updatesBrederode SA to Report First Half, 2023 Results on Sep 14, 2023Brederode SA announced that they will report first half, 2023 results on Sep 14, 2023Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €97.50, the stock trades at a trailing P/E ratio of 2.6x. Average trailing P/E is 11x in the Capital Markets industry in Europe. Total returns to shareholders of 62% over the past three years.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Is New 90 Day High Low • Mar 11New 90-day high: €88.20The company is up 10.0% from its price of €80.50 on 11 December 2020. The Luxembourger market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 9.0% over the same period.Is New 90 Day High Low • Jan 23New 90-day high: €85.00The company is up 13% from its price of €75.00 on 23 October 2020. The Luxembourger market is up 7.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Capital Markets industry, which is up 17% over the same period.Is New 90 Day High Low • Nov 27New 90-day high: €80.00The company is up 6.0% from its price of €75.30 on 28 August 2020. The Luxembourger market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 29New 90-day low: €71.80The company is down 4.0% from its price of €74.50 on 30 July 2020. The Luxembourger market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 5.0% over the same period.Is New 90 Day High Low • Sep 29New 90-day high: €78.50The company is up 5.0% from its price of €74.60 on 01 July 2020. The Luxembourger market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 1.0% over the same period.収支内訳Brederode の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BDL:BREL 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 25891240030 Sep 2552870030 Jun 2514500031 Mar 251962320031 Dec 243774130030 Sep 243063430030 Jun 242362720031 Mar 242202530031 Dec 232052340030 Sep 231711990030 Jun 231371650031 Mar 2317460031 Dec 22-103-730030 Sep 221211510030 Jun 223453750031 Mar 226747050031 Dec 211,0041,0360030 Sep 219329640030 Jun 218608920031 Mar 215465770031 Dec 202322620030 Sep 201832130030 Jun 201351650031 Mar 202823110031 Dec 194304580030 Sep 193563840030 Jun 192823100031 Mar 192202460031 Dec 181571820030 Sep 181752000030 Jun 181932180031 Mar 181701940031 Dec 171471700030 Sep 171802030030 Jun 172142370031 Mar 171932040031 Dec 161721720030 Sep 161221221030 Jun 1673722031 Mar 161511482031 Dec 152292242030 Sep 152522483030 Jun 1527627200質の高い収益: BRELは 高品質の収益 を持っています。利益率の向上: BRELの現在の純利益率 は、昨年よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: BRELの収益は過去 5 年間で年間33%減少しました。成長の加速: BRELは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: BRELは過去 1 年間で収益成長率がマイナス ( -69.9% ) となったため、 Capital Markets業界平均 ( 19.6% ) と比較することが困難です。株主資本利益率高いROE: BRELの 自己資本利益率 ( 2.9% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YDiversified-financials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 21:28終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Brederode SA 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jan 09+ 3 more updatesBrederode SA to Report First Half, 2026 Results on Sep 10, 2026Brederode SA announced that they will report first half, 2026 results on Sep 10, 2026
お知らせ • Dec 06+ 3 more updatesBrederode SA to Report Nine Months, 2025 Results on Dec 11, 2025Brederode SA announced that they will report nine months, 2025 results on Dec 11, 2025
お知らせ • Dec 13+ 4 more updatesBrederode SA to Report Q3, 2024 Results on Dec 05, 2024Brederode SA announced that they will report Q3, 2024 results on Dec 05, 2024
お知らせ • Dec 21+ 3 more updatesBrederode SA to Report First Half, 2023 Results on Sep 14, 2023Brederode SA announced that they will report first half, 2023 results on Sep 14, 2023
Buy Or Sell Opportunity • Feb 25Now 21% overvaluedOver the last 90 days, the stock has fallen 1.5% to €105. The fair value is estimated to be €87.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 16%.
お知らせ • Jan 09+ 3 more updatesBrederode SA to Report First Half, 2026 Results on Sep 10, 2026Brederode SA announced that they will report first half, 2026 results on Sep 10, 2026
お知らせ • Dec 06+ 3 more updatesBrederode SA to Report Nine Months, 2025 Results on Dec 11, 2025Brederode SA announced that they will report nine months, 2025 results on Dec 11, 2025
Buy Or Sell Opportunity • Dec 05Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.5% to €104. The fair value is estimated to be €130, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
Buy Or Sell Opportunity • Nov 12Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at €105. The fair value is estimated to be €132, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
Buy Or Sell Opportunity • Oct 23Now 20% undervaluedOver the last 90 days, the stock has risen 1.8% to €110. The fair value is estimated to be €139, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
Buy Or Sell Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.6% to €112. The fair value is estimated to be €140, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
お知らせ • Dec 13+ 4 more updatesBrederode SA to Report Q3, 2024 Results on Dec 05, 2024Brederode SA announced that they will report Q3, 2024 results on Dec 05, 2024
Buying Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.9%. The fair value is estimated to be €118, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Earnings per share has declined by 24%.
New Risk • Aug 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risk Shareholders have been diluted in the past year (4.3% increase in shares outstanding).
お知らせ • Dec 21+ 3 more updatesBrederode SA to Report First Half, 2023 Results on Sep 14, 2023Brederode SA announced that they will report first half, 2023 results on Sep 14, 2023
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €97.50, the stock trades at a trailing P/E ratio of 2.6x. Average trailing P/E is 11x in the Capital Markets industry in Europe. Total returns to shareholders of 62% over the past three years.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Is New 90 Day High Low • Mar 11New 90-day high: €88.20The company is up 10.0% from its price of €80.50 on 11 December 2020. The Luxembourger market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Jan 23New 90-day high: €85.00The company is up 13% from its price of €75.00 on 23 October 2020. The Luxembourger market is up 7.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Capital Markets industry, which is up 17% over the same period.
Is New 90 Day High Low • Nov 27New 90-day high: €80.00The company is up 6.0% from its price of €75.30 on 28 August 2020. The Luxembourger market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 29New 90-day low: €71.80The company is down 4.0% from its price of €74.50 on 30 July 2020. The Luxembourger market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 5.0% over the same period.
Is New 90 Day High Low • Sep 29New 90-day high: €78.50The company is up 5.0% from its price of €74.60 on 01 July 2020. The Luxembourger market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 1.0% over the same period.